Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesNon-Current ReceivablesReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Braskem (BAK) Cost of Revenue (2016 - 2025)

Braskem has reported Cost of Revenue over the past 16 years, most recently at $3.1 billion for Q1 2025.

  • For Q1 2025, Cost of Revenue changed N/A year-over-year to $3.1 billion; the TTM value through Mar 2025 reached $27.2 billion, changed N/A, while the annual FY2025 figure was $12.8 billion, 4.39% up from the prior year.
  • Cost of Revenue for Q1 2025 was $3.1 billion at Braskem, down from $17.2 billion in the prior quarter.
  • Over five years, Cost of Revenue peaked at $17.2 billion in Q4 2023 and troughed at $3.1 billion in Q1 2025.
  • A 4-year average of $5.9 billion and a median of $3.7 billion in 2021 define the central range for Cost of Revenue.
  • On a YoY basis, Cost of Revenue climbed as much as 374.6% in 2023 and fell as far as 25.33% in 2023.
  • Year by year, Cost of Revenue stood at $3.9 billion in 2021, then fell by 6.01% to $3.6 billion in 2022, then surged by 374.6% to $17.2 billion in 2023, then tumbled by 81.99% to $3.1 billion in 2025.
  • Business Quant data shows Cost of Revenue for BAK at $3.1 billion in Q1 2025, $17.2 billion in Q4 2023, and $3.3 billion in Q3 2023.